Design and Development of Drug-Monoclonal Antibody 791T/36 Conjugate for Cancer Therapy
- 1 January 1985
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Preparation of four daunomycin‐monoclonal antibody 79IT/36 conjugates with anti‐tumour activityInternational Journal of Cancer, 1984
- The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumoursBritish Journal of Surgery, 1984
- Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenograftsEuropean Journal of Cancer and Clinical Oncology, 1984
- Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitroInternational Journal of Cancer, 1983
- Immunotoxins: A New Approach to Cancer TherapyScience, 1983
- Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugateBritish Journal of Cancer, 1983
- Characteristics of a cell surface antigen defined by an anti-human osteogenic sarcoma monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1983
- RADIOIMMUNODETECTION OF HUMAN COLORECTAL CANCERS BY AN ANTI-TUMOUR MONOCLONAL ANTIBODYThe Lancet, 1982
- In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenograftsInternational Journal of Cancer, 1982
- Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity.Proceedings of the National Academy of Sciences, 1982